GlaxoSmithKline PLC
- SEC CIK
- 0001131399
In the past year, 1 open-market purchase filing worth $27.9M and no sales.
Current role at each company
- WVE Wave Life Sciences, Inc.10% Owneras of Dec 15, 2025
- TBPH Theravance Biopharma, Inc.Other: Former 10% Owneras of Sep 20, 2022
- CVRX CVRx, Inc.10% Owneras of Jul 6, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $27.9M
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$27.9M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists GlaxoSmithKline PLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
WVE Wave Life Sciences, Inc.
10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 (view filing) | Dec 11 | 4 days | GlaxoSmithKline PLC10% Owner | PPurchase | +1.47M | $19.00 | +$27.9M | +8.8%18.2M after | |
| Oct 1, 2024 (view filing) | Sep 27 | 4 days | GlaxoSmithKline PLC10% Owner | PPurchase | +2.79M | $8.00 | +$22.3M | +20.0%16.8M after | |
| Jan 30, 2024 (view filing) | Dec 7, 2023 | 54 daysLate | GlaxoSmithKline PLC10% Owner | PPurchase | +3.30M | $5.00 | +$16.5M | +30.9%14.0M after |
CVRX CVRx, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2021 (view filing) | Jul 2 | 4 days | GlaxoSmithKline PLC10% Owner | PPurchase | +275.0K | $18.00 | +$4.95M | +37.5%1.01M after |